Melanoma,Skin Cancer Path Response to Neoadjuvant Nivo and Rela in High-Risk Stage II Melanoma Sep 07, 2023
Melanoma Combination Therapy of Cobimetinib and Atezolizumab in BRAFV600 Wild-Type Melanoma Patients Aug 29, 2023
Melanoma,Skin Cancer Anti-LAG-3 Plus Anti-PD-1 Vs. Pembrolizumab in Pts With Completely Resected High-Risk Melanoma Aug 14, 2023
Melanoma,Skin Cancer Phase 3 Trial: Fianlimab + Cemiplimab vs. Pembrolizumab in High-Risk Melanoma Jul 31, 2023
Melanoma,Skin Cancer 1L Atezolizumab With Vemurafenib and Cobimetinib Improves OS in BRAFV600 Advanced Melanoma Jun 01, 2023
Melanoma,Skin Cancer NNT and NNH Utilized to Assess the Efficacy and Safety of Adjuvant Therapies in Melanoma Jun 01, 2023
Melanoma,Skin Cancer Tumor Biomarker Analysis of Encorafenib + Binimetinib in Advanced Melanoma Jun 01, 2023